Switch to
| Predicate | Object |
|---|---|
| rdf:type | |
| lifeskim:mentions | |
| pubmed:issue |
14
|
| pubmed:dateCreated |
1996-11-8
|
| pubmed:abstractText |
Anemia is common complication in multiple myeloma (MM). Its etiology is multifactorial-bone marrow infiltration, cytokines production, renal failure and effect of chemotherapy are main contributing factors. The red cell substitution therapy, which is administrated in 34 - 53% of patients, is frequently associated with the risk of well-known side effects. The use of recombinant erythropoietin (r-HuEPO) is a novel therapy in patients with MM.
|
| pubmed:language |
cze
|
| pubmed:journal | |
| pubmed:citationSubset |
IM
|
| pubmed:chemical | |
| pubmed:status |
MEDLINE
|
| pubmed:month |
Jul
|
| pubmed:issn |
0008-7335
|
| pubmed:author | |
| pubmed:issnType |
Print
|
| pubmed:day |
14
|
| pubmed:volume |
135
|
| pubmed:owner |
NLM
|
| pubmed:authorsComplete |
Y
|
| pubmed:pagination |
450-3
|
| pubmed:dateRevised |
2011-11-17
|
| pubmed:meshHeading |
pubmed-meshheading:8925545-Aged,
pubmed-meshheading:8925545-Anemia,
pubmed-meshheading:8925545-Erythropoietin,
pubmed-meshheading:8925545-Female,
pubmed-meshheading:8925545-Humans,
pubmed-meshheading:8925545-Male,
pubmed-meshheading:8925545-Middle Aged,
pubmed-meshheading:8925545-Multiple Myeloma,
pubmed-meshheading:8925545-Recombinant Proteins
|
| pubmed:year |
1996
|
| pubmed:articleTitle |
[Recombinant erythropoietin (r-HuEPO) in the treatment of anemia in multiple myeloma].
|
| pubmed:affiliation |
I. interní klinika 1. LF UK a VFN, Praha.
|
| pubmed:publicationType |
Journal Article,
English Abstract
|